Cleared Traditional

K811069 - FIBRINOGEN CONTROL PLASMA

K811069 is the FDA 510(k) clearance for FIBRINOGEN CONTROL PLASMA by American Dade. It is a Class 2 Hematology device (product code KQJ) cleared through the Traditional 510(k) pathway after a 81-day FDA review.

K811069 · American Dade · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1981
Decision
81d
Days
Class 2
Risk

K811069 is an FDA 510(k) clearance for the FIBRINOGEN CONTROL PLASMA. Classified as System, Fibrinogen Determination (product code KQJ), Class II - Special Controls.

Submitted by American Dade (Mchenry, US). The FDA issued a Cleared decision on July 10, 1981 after a review of 81 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7340 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all American Dade devices

Submission Details

510(k) Number K811069 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 20, 1981
Decision Date July 10, 1981
Days to Decision 81 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 113d · This submission: 81d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KQJ System, Fibrinogen Determination
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - KQJ System, Fibrinogen Determination

All 21
Devices cleared under the same product code (KQJ) and FDA review panel - the closest regulatory comparables to K811069.
ACA FIBRINOGEN TEST PACK
K812629 · E.I. Dupont DE Nemours & Co., Inc. · Oct 1981
LABCER FIBRINOGEN ASSAY KIT & CALIBR.
K812570 · Sherwood Medical Co. · Oct 1981
LOW FIBRINOGEN CONTROL
K812108 · Bio/Data Corp. · Sep 1981
ORTHO QUANTITATIVE FIBRINOGEN ASSAY
K810058 · Ortho Diagnostic Systems, Inc. · Feb 1981
SIGMA PROCEDURE #880 FIBRINOGIN/PLASMA
K801926 · Sigma Chemical Co. · Sep 1980
THROMBOKINETIC FIBRINOGEN ASSAY
K792563 · Bio/Data Corp. · Jan 1980